Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Northrop Grumman Corporation (NOC) vs 22nd Century Group Inc (XXII) Price & Performance

Northrop Grumman CorporationTrade
22nd Century Group IncTrade

Price performance (Past 24H)

Key statistics

Northrop Grumman Corporation vs 22nd Century Group Inc — how do they compare? Northrop Grumman Corporation trades at $480.06 (market cap $68.83B), while 22nd Century Group Inc trades at $0.8 (market cap $621.67K). The key difference: Northrop Grumman Corporation is far larger — about 110717.9× 22nd Century Group Inc's market cap, and Northrop Grumman Corporation pays a 2.04% dividend while 22nd Century Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Northrop Grumman Corporation for 81 Days and 22nd Century Group Inc for 32 Days on average.

NOCXXII
Market Cap
$68.83B$621.67K
Volume
1,081,98945,625
Sector
IndustrialsConsumer Staples
52-Week High
$768.02$483.00
52-Week Low
$473.46$0.80
Typical Hold Time
81 Days32 Days
Enterprise Value
$82.81B-$3.69M
Dividend Yield
2.04%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Northrop Grumman Corporation

Northrop Grumman (NOC) trades at $480.85, up 1.56% with recent earnings beats but faces technical bearish signals. The company maintains strong fundamentals with $41.95B revenue, 10.48% net margin, and attractive valuation at 15.4 P/E. Recent news highlights both contract wins and competitive losses, including Boeing's $20B Navy fighter award.

Outlook remains positive with analyst consensus at $600.62 target (25% upside) and 54% buy ratings. Key risks include defense contract volatility and competitive pressures, while strong backlog ($104.7B) and dividend growth support long-term value. The stock offers defensive exposure to elevated defense spending cycles.

22nd Century Group Inc

22nd Century Group (XXII) trades at $0.89, down 0.94% today, with a bearish technical signal despite oversold RSI readings. The company shows severe financial stress with negative gross margins of -54.6% and net income margin of -76.01%, though valuation metrics appear low with P/S of 0.09 and P/B of 0.03. Recent news highlights regulatory progress in nicotine reduction initiatives and expanded retail distribution for VLN products.

While analyst consensus remains bullish with 75% buy ratings and a $1,240 price target, fundamental challenges persist with consecutive earnings misses and negative cash flow from operations. The stock presents high-risk speculation on regulatory adoption of reduced-nicotine standards, requiring careful risk assessment given the company's ongoing losses and cash burn.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NOC

No sentiment data available yet.

XXII
100% Buy0% Sell
Avg holding period · 32 Days

Top news

Latest headlines on both assets

About Northrop Grumman Corporation

Northrop Grumman is a defense contractor that is diversified across short-cycle and long-cycle businesses. The firm's segments include aeronautics, mission systems, defense services, and space systems. The company's aerospace segment creates the fuselage for the massive F-35 program and produces various piloted and autonomous flight systems. Mission systems creates a variety of sensors and processors for defense hardware. The defense systems segment is a long-range missile manufacturer. Finally, the company's space systems segment produces various space structures, sensors, and satellites.

Read more on NOC →

About 22nd Century Group Inc

22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.

Read more on XXII →